Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Hydrogels for preventing post-endoscopic submucosal dissection stenosis in early esophageal cancer: a comprehensive literature review

Wu J., Guo CG., Zhao Y., Wang J., Liu J., Li P.

Narrative Review on Systemic / IV, published in Ther Adv Gastroenterol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Ther Adv Gastroenterol (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40607166
PMCID
PMC12214328
DOI
10.1177/17562848251348971
Citations
1

Abstract (original English)

Endoscopic submucosal dissection (ESD) has emerged as a cornerstone therapy for early-stage esophageal cancer due to its minimally invasive characterization and high efficacy. However, postoperative esophageal stricture remains a critical complication, particularly in cases involving circumferential mucosal defects, with reported incidence rates exceeding 80%. Conventional preventive strategies, including local or systemic steroid administration, esophageal stent placement, and repeated balloon dilation, are limited by side-effect concerns, procedural complexity, and suboptimal long-term outcomes. Recent advancements in regenerative medicine have highlighted hydrogels as innovative tissue-shielding materials with significant potential to mitigate post-ESD stenosis. These hydrophilic polymer networks exhibit unique advantages such as biocompatibility, tunable mechanical properties, and the ability to transfer therapeutic agents directly to the wound. This review synthesizes current evidence on synthetic and natural hydrogels, emphasizing their mechanisms in promoting epithelial regeneration, reducing fibrosis, and synergizing with current therapies (e.g., steroid-loaded formulations or stent placement). Key findings suggest that hydrogel-based interventions significantly lower stricture rates and minimize the need for invasive procedures, offering a promising paradigm shift in p

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research